These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30746510)

  • 1. The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response.
    Mullooly M; Gierach GL
    JNCI Cancer Spectr; 2018 Nov; 2(4):pky072. PubMed ID: 30746510
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.
    Li J; Humphreys K; Eriksson L; Edgren G; Czene K; Hall P
    J Clin Oncol; 2013 Jun; 31(18):2249-56. PubMed ID: 23610119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.
    Eriksson L; He W; Eriksson M; Humphreys K; Bergh J; Hall P; Czene K
    JNCI Cancer Spectr; 2018 Oct; 2(4):pky071. PubMed ID: 31360886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to Mammographic Density Decrease After Exposure to Tamoxifen.
    Bäcklund M; Eriksson M; Hammarström M; Thoren L; Bergqvist J; Margolin S; Hellgren R; Wengström Y; Gabrielson M; Czene K; Hall P
    Oncologist; 2022 Jul; 27(7):e601-e603. PubMed ID: 35605013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.
    Thorén L; Eriksson M; Lindh JD; Czene K; Bergh J; Eliasson E; Hall P; Margolin S
    Breast Cancer Res Treat; 2021 Dec; 190(3):451-462. PubMed ID: 34570302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
    Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.
    van Nes JG; Beex LV; Seynaeve C; Putter H; Sramek A; Lardenoije S; Duijm-de Carpentier M; Van Rongen I; Nortier JW; Zonderland HM; van de Velde CJ
    Acta Oncol; 2015 Mar; 54(3):349-60. PubMed ID: 25383451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.
    Andersson TM; Crowther MJ; Czene K; Hall P; Humphreys K
    Am J Epidemiol; 2017 Nov; 186(9):1065-1073. PubMed ID: 28633324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
    Kim WH; Cho N; Kim YS; Yi A
    Eur Radiol; 2018 Aug; 28(8):3176-3184. PubMed ID: 29626240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.
    Eriksson M; Eklund M; Borgquist S; Hellgren R; Margolin S; Thoren L; Rosendahl A; Lång K; Tapia J; Bäcklund M; Discacciati A; Crippa A; Gabrielson M; Hammarström M; Wengström Y; Czene K; Hall P
    J Clin Oncol; 2021 Jun; 39(17):1899-1908. PubMed ID: 33734864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years.
    Brentnall AR; Warren R; Harkness EF; Astley SM; Wiseman J; Fox J; Fox L; Eriksson M; Hall P; Cuzick J; Evans DG; Howell A
    Breast Cancer Res; 2020 Sep; 22(1):101. PubMed ID: 32993747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can tamoxifen cause a significant mammographic density change in breast parenchyma?
    Konez O; Goyal M; Reaven RE
    Clin Imaging; 2001; 25(5):303-8. PubMed ID: 11682285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
    Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
    J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.
    Mullooly M; Pfeiffer RM; Nyante SJ; Heckman-Stoddard BM; Perloff M; Jatoi I; Brinton LA; Aiello Bowles EJ; Hoover RN; Glass A; Berrington de Gonzalez A; Sherman ME; Gierach GL
    J Clin Oncol; 2016 Jun; 34(18):2093-7. PubMed ID: 27022110
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients.
    Ko KL; Shin IS; You JY; Jung SY; Ro J; Lee ES
    Breast Cancer Res Treat; 2013 Dec; 142(3):559-67. PubMed ID: 24233999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen in women with breast cancer and mammographic density.
    Meggiorini ML; Labi L; Vestri AR; Porfiri LM; Savelli S; De Felice C
    Eur J Gynaecol Oncol; 2008; 29(6):598-601. PubMed ID: 19115686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.
    Shawky MS; Martin H; Hugo HJ; Lloyd T; Britt KL; Redfern A; Thompson EW
    Oncotarget; 2017 Jan; 8(3):5578-5591. PubMed ID: 27894075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen on breast tissue density in premenopausal breast cancer.
    Slanetz PJ; Grandpre LE; Yeh ED; Kopans DB; Mendel JB
    Breast J; 2004; 10(1):27-32. PubMed ID: 14717756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.
    Atkinson C; Warren R; Bingham SA; Day NE
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):863-6. PubMed ID: 10548313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic Density Reduction is Associated to the Prognosis in Asian Breast Cancer Patients Receiving Hormone Therapy.
    Shia WC; Lin LS; Wu HK; Chen CJ; Chen DR
    Cancer Control; 2023; 30():10732748231160991. PubMed ID: 36866691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.